Quality of life during lanadelumab treatment in patients with hereditary angioedema: 24-month results from the enable study

被引：0
|
作者：
Saguer, I. Martinez [1 ]
Magerl, M. [2 ,3 ]
Andriotti, T. [4 ]
Botha, J. [5 ]
Agmon-Levin, N. [6 ]
Watt, M. [4 ]
Maurer, M. [3 ,7 ]
机构：
[1] HRZM Hemophilia Ctr Rhein Main, Morfelden Walldorf, Germany
[2] Charite Univ Med Berlin, Inst Allergol, Berlin, Germany
[3] Fraunhofer Inst Translat Med & Pharmacol ITMP, Berlin, Germany
[4] Takeda Dev Ctr Amer Inc, Lexington, KY USA
[5] Takeda Pharmaceut Int AG, Zurich, Switzerland
[6] Tel Hashomer Hosp, Ctr Autoimmune Dis, Sheba Med Ctr, Ramat Gan, Israel
[7] Charite Univ Med Berlin, Inst Allergol, Berlin, Germany
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000902
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [1] Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study
    Lumry, William R.
    Weller, Karsten
    Magerl, Markus
    Banerji, Aleena
    Longhurst, Hilary J.
    Riedl, Marc A.
    Lewis, Hannah B.
    Lu, Peng
    Devercelli, Giovanna
    Jain, Gagan
    Maurer, Marcus
    [J]. ALLERGY, 2021, 76 (04) : 1188 - 1198
  • [2] QUALITY OF LIFE OF HEREDITARY ANGIOEDEMA (HAE) PATIENTS WITH DEPRESSION OR ANXIETY RECEIVING LANADELUMAB
    Craig, T.
    Soteres, D.
    Anderson, J.
    Paes, K.
    Hao, J.
    Hashemi, L.
    Watt, M.
    Juethner, S.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S25 - S25
  • [3] Effectiveness, Safety, and Patient-Reported Outcomes (PROs) in Patients With Hereditary Angioedema (HAE) From the United States and Canada Treated With Lanadelumab: 24-Month Data From the EMPOWER Study
    Wedner, H. James
    Bernstein, Jonathan
    Betschel, Stephen
    Manning, Michael
    Estepan, Daniel Nova
    Fei, Kezhen
    Yegin, Ashley
    Watt, Maureen
    Chavan, Sunetra
    Busse, Paula
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB131 - AB131
  • [4] Lanadelumab Markedly Improves Health-related Quality of Life in Hereditary Angioedema Patients in the HELP Study
    Lumry, W. R.
    Weller, K.
    Magerl, M.
    Lu, P.
    Jain, G.
    Lewis, H.
    Bruelle, J.
    Maurer, M.
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 28S - 28S
  • [5] Health-Related Quality of Life (HRQoL) in Pediatric Patients with Hereditary Angioedema (HAE) Receiving Lanadelumab: Exploratory Results From the SPRING Study
    Watt, Maureen
    Maurer, Marcus
    Lumry, William
    Li, H. Henry
    Aygoeren-Puersuen, Emel
    Busse, Paula
    Jacobs, Joshua
    Nurse, Christina
    Yu, Ming
    Romanus, Dorothy
    Devercelli, Giovanna
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB139 - AB139
  • [6] Lanadelumab Markedly Improves Health-related Quality of Life in Hereditary Angioedema Patients in the HELP Study
    Lumry, William R.
    Weller, Karsten
    Magerl, Markus
    Schranz, Jennifer
    Jain, Gagan
    Doll, Helen
    Maurer, Marcus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB47 - AB47
  • [7] Lanadelumab improves health-related quality of life in patients with hereditary Angioedema (HAE): findings from the HELP study
    Longhurst, Hilary
    Lumry, William
    Weller, Karsten
    Magerl, Markus
    Lu, Peng
    Jain, Gagan
    Lewis, Hannah
    Maurer, Marcus
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (11): : 1524 - 1525
  • [8] Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedema
    Lumry, William R.
    Maurer, Marcus
    Weller, Karsten
    Riedl, Marc A.
    Watt, Maureen
    Yu, Ming
    Devercelli, Giovanna
    Meunier, Juliette
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (01) : 101 - +
  • [9] SUSTAINED IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE WITH CONTINUED LANADELUMAB TREATMENT IN HEREDITARY ANGIOEDEMA
    Watt, M.
    Devercelli, G.
    Lumry, W.
    Maurer, M.
    Weller, K.
    Riedl, M.
    Meunier, J.
    Banerji, A.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S27 - S27
  • [10] LONG-TERM EFFICACY, SAFETY, AND QUALITY OF LIFE WITH LANADELUMAB TREATMENT IN ADOLESCENTS WITH HEREDITARY ANGIOEDEMA
    Craig, T.
    Tachdjian, R.
    Bernstein, J.
    Anderson, J.
    Nurse, C.
    Watt, M.
    Juethner, S.
    Yu, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S28 - S28
12345